Competitive intelligence for pharma and biotech teams
Follow competitor pipelines, trial readouts, approvals and deals across news, trade press and the sources you add. Briefweb turns them into cited alerts, weekly briefings and research reports, without a database contract.
Pharmaceutical competitive intelligence tracks what rival drug developers do next.
Pipelines and readouts: New programs, phase transitions and trial results as companies and trade press report them. Deals and launches: Licensing, acquisitions, pricing and launches that shift a market. Briefweb does both: alerts when something moves, and a cited report when you need depth, with every point linked to its source.
Follow competitor pipelines and trial readouts
Track named competitors and drug classes across global news, pharma trade press and any company newsroom or RSS feed you add. Briefweb groups repeat coverage of the same readout into one development, so a phase 3 result reads as one event, not forty headlines.
Catch approvals and regulatory decisions early
Follow approvals, label changes and agency guidance as they are reported, and add an agency's press release page or RSS feed as a custom source. For deeper regulatory intelligence in pharma, track the rule changes themselves with regulatory monitoring.
Understand deals, patents and launches
When a licensing deal or a launch changes your market, ask a question and Briefweb runs deep research across current news and trade press. You get a cited report with key findings, a comparison of the main players, a timeline and what to watch next, ready to download as PDF or Word. Every point links to its source, so you can check it against the records you already trust.
Real pipeline moves, tracked to their sources
A report opens with a cited summary, then key findings, the developments behind them, a policy table and what to watch next. For example, this finding comes from our report on how competitors are challenging Novo Nordisk and Eli Lilly in GLP-1 obesity drugs, built from 62 articles across 46 sources over 90 days.
How pharma competitive intelligence works
Name what to track: Competitors, drug classes, targets or indications, as monitored topics. Briefweb watches the sources: News, pharma trade press and your custom sources, checked daily or weekly and weighted by how widely a development is reported. Get alerts, briefings or a report: Email alerts on major developments, a weekly competitor digest, or a full cited report when a decision needs depth.
Built for teams that plan against competitors
Competitive intelligence and strategy: Rival pipelines, readouts and launches across your therapeutic areas, in one weekly briefing. Business development and licensing: Deals, partnerships and assets changing hands, with cited coverage for screening memos. Medical and commercial teams: Approvals, label changes and launch news that shape how you position a product. Life sciences investors: Readouts, financings and regulatory decisions across a portfolio, with a source for every point.
Explore more
- Competitor tracking
Track competitors across news and trade press.
- Regulatory monitoring
Monitor regulators and policy change.
- Market intelligence reports
Turn a market question into a cited report.
- AI agents
How Briefweb's AI agents track competitors.
Frequently asked questions
What is pharmaceutical competitive intelligence?
Pharmaceutical competitive intelligence is the ongoing tracking of what other drug developers are doing: pipeline progress, trial readouts, regulatory decisions, licensing deals, patents and launches. Teams use it to time their own programs, find partners and prepare for competing launches. Briefweb supports pharma and biotech competitive intelligence across the open web, with every point linked to its source.
Which sources does Briefweb monitor?
Global news and pharma trade publications, plus any company newsroom, regulator page or RSS feed you add as a custom source.
What should I look for in competitive intelligence software for pharma?
Check four things. Coverage: which companies, drug classes and sources it watches. Briefweb covers global news and pharma trade press plus any newsroom, regulator page or RSS feed you add. Citations: whether every point traces to its source. Every statement in a Briefweb briefing or report links to one. Alert speed: how quickly you hear about a readout or decision. Briefweb checks topics daily or weekly and alerts you when coverage rises sharply. Export: whether you can share the output. Digests go out by email on a schedule, and reports download as PDF or Word.
How is Briefweb different from a pipeline database?
Curated pipeline databases record structured data on every program and suit large teams with a database contract. Briefweb monitors the open web for what changed: readouts, decisions, deals and launches, delivered as cited briefings and reports. Biotech and mid-size pharma teams use it to follow competitors without that contract, and larger teams use it alongside a database.
Is Briefweb medical, regulatory or investment advice?
No. Briefweb summarizes reported developments and links each point to its source. Clinical, regulatory and investment decisions remain with your qualified teams.